oxyphenbutazone has been researched along with Psoriasis in 7 studies
Oxyphenbutazone: A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27)
oxyphenbutazone : A metabolite of phenylbutazone obtained by hydroxylation at position 4 of one of the phenyl rings. Commonly used (as its hydrate) to treat pain, swelling and stiffness associated with arthritis and gout, it was withdrawn from the market 1984 following association with blood dyscrasis and Stevens-Johnson syndrome.
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe two patients who developed generalized pustular psoriasis after taking phenylbutazone and oxyphenbutazone respectively, and discuss the possible pharmacological mechanism of this effect." | 7.66 | Generalized pustular psoriasis precipitated by phenylbutazone and oxyphenbutazone. ( Hargreaves, GK; Reshad, H; Vickers, CF, 1983) |
| "We describe two patients who developed generalized pustular psoriasis after taking phenylbutazone and oxyphenbutazone respectively, and discuss the possible pharmacological mechanism of this effect." | 3.66 | Generalized pustular psoriasis precipitated by phenylbutazone and oxyphenbutazone. ( Hargreaves, GK; Reshad, H; Vickers, CF, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| SPERLING, IL | 1 |
| Versteegh, MI | 1 |
| Vijverberg, PL | 1 |
| van Dijk, HA | 1 |
| Reshad, H | 1 |
| Hargreaves, GK | 1 |
| Vickers, CF | 1 |
| Ring, EF | 1 |
| Roberts, ME | 1 |
| Wright, V | 1 |
| Hill, AG | 1 |
| Mehra, AC | 1 |
| Cosh, JA | 1 |
| Heber, W | 1 |
2 reviews available for oxyphenbutazone and Psoriasis
| Article | Year |
|---|---|
Thermography and rheumatic diseases.
Topics: Adrenocorticotropic Hormone; Arthritis; Arthritis, Juvenile; Arthritis, Rheumatoid; Body Temperature | 1975 |
[Isomorphic response in psoriasis vulgaris. Review and observations].
Topics: Adolescent; Adult; Aged; Amputation, Surgical; Antifungal Agents; Child; Cicatrix; Female; Glucocort | 1974 |
5 other studies available for oxyphenbutazone and Psoriasis
| Article | Year |
|---|---|
3 YEARS' EXPERIENCE WITH OXYPHENBUTAZONE IN THE TREATMENT OF RHEUMATIC DISORDERS.
Topics: Adolescent; Arthritis; Arthritis, Rheumatoid; Geriatrics; Gout; Osteoarthritis; Oxyphenbutazone; Pso | 1964 |
[Pancreas irritation caused by oxyphenbutazone (Tanderil)].
Topics: Adult; Amylases; Arthritis; Female; Humans; Oxyphenbutazone; Pancreatitis; Psoriasis | 1983 |
Generalized pustular psoriasis precipitated by phenylbutazone and oxyphenbutazone.
Topics: Adult; Aged; Female; Humans; Oxyphenbutazone; Phenylbutazone; Psoriasis | 1983 |
Psoriatic arthritis. Follow-up study.
Topics: Adult; Age Factors; Aged; Agglutination Tests; Arthritis; Arthritis, Rheumatoid; Female; Follow-Up S | 1976 |
Anti-inflammatory drugs in rheumatic diseases.
Topics: Adrenocorticotropic Hormone; Anti-Inflammatory Agents; Antimalarials; Arthritis, Rheumatoid; Aspirin | 1974 |